Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2015)

Cost Effectiveness of ‘On Demand’ Hiv Pre-Exposure Prophylaxis for Non-Injection Drug-Using Men Who Have Sex with Men in Canada

  • Estelle Ouellet,
  • Madeleine Durand,
  • Jason R Guertin,
  • Jacques LeLorier,
  • Cécile L Tremblay

DOI
https://doi.org/10.1155/2015/964512
Journal volume & issue
Vol. 26, no. 1
pp. 23 – 29

Abstract

Read online

BACKGROUND: Recent trials report the efficacy of continuous tenofovir-based pre-exposure prophylaxis (PrEP) for prevention of HIV infection. The cost effectiveness of ‘on demand’ PrEP for non-injection drug-using men who have sex with men at high risk of HIV acquisition has not been evaluated.